We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Novel Diagnostic Test Assesses Risk of Urinary Uric Acid Crystallization

By LabMedica International staff writers
Posted on 20 May 2021
Print article
Image: Photomicrograph of uric acid crystals in urine sediment (Photo courtesy of cannablysss)
Image: Photomicrograph of uric acid crystals in urine sediment (Photo courtesy of cannablysss)
Uric acid (UA) kidney stones account for 10% to 11% of all kidney stones, and this percentage has increased over time. An accurate, rapid, simple, and low-cost test is needed to distinguish urine that is susceptible and resistant to the formation of UA crystals.

Renal stone formation is a multifactorial process that is affected by urine composition and other factors, such as structural and pathological features of the kidneys, which include the presence of renal cavities with low urodynamic efficiency that retain urine for long periods, and alterations of the epithelial cells that cover the renal papillae.

Urology Scientists at the University of Balearic Islands (Palma de Mallorca, Spain) and their colleagues collected urine samples from 20 healthy adult volunteers and 54 active formers of UA stones. Three samples were collected from each participant, with at least seven days between each collection. The main lithogenic parameters for UA stones were determined, and the risk of UA crystallization (RUAC test) was performed in all urine samples.

The team reported that the ROC analysis indicated the area under the curve (AUC) was 0.881 (95% CI: 0.831 to 0.932), the sensitivity was 78.5%, the specificity was 92.4%, and the Youden index was 0.709. Based on this analysis, the optimum cutoff value was five positive wells. The diagnostic specifications of RUAC test data, when considering that a urine is lithogenic with respect to UA when its SS is greater than 2 and the RUAC test is positive when crystals formed in five or more wells. A total of 61% of basal urine from UA stone formers were positive in the RUAC test, but only 19% of healthy volunteers were positive in the basal urine. Furthermore, among UA stone formers, the percentage of patients with a positive RUAC test decreased from 61% to 40% after treatment with theobromine. However, among healthy volunteers, the decrease after treatment with chocolate powder was not significant.

The authors concluded the RUAC test has high diagnostic accuracy and low cost, and is also rapid and simple. This test can therefore be used as a screening tool in clinics and reference laboratories, in locations with limited laboratory infrastructure, and by community health workers with minimal training. This test demonstrates that the value of uric acid supersaturation in a urine, would also be a useful parameter, since for SS>2, the urine would be lithogenic for uric acid. The study was published on May 6, 2021 in the journal Clinica Chimica Acta.

Related Links:
University of Balearic Islands

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.